These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 11132026)

  • 1. Angiotensin II: a double-edged sword in inflammation.
    Suzuki Y; Ruiz-Ortega M; Egido J
    J Nephrol; 2000; 13 Suppl 3():S101-10. PubMed ID: 11132026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiotensin II and vascular inflammation.
    Cheng ZJ; Vapaatalo H; Mervaala E
    Med Sci Monit; 2005 Jun; 11(6):RA194-205. PubMed ID: 15917731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of the renin-angiotensin system in vascular inflammation.
    Marchesi C; Paradis P; Schiffrin EL
    Trends Pharmacol Sci; 2008 Jul; 29(7):367-74. PubMed ID: 18579222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pathophysiological and clinical implications of AT(1) and AT(2) angiotensin II receptors in metabolic disorders: hypercholesterolaemia and diabetes].
    Strawn WB
    Drugs; 2002; 62 Spec No 1():31-41. PubMed ID: 12036387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Essential hypertension: is there a role for inflammatory mechanisms?
    Androulakis ES; Tousoulis D; Papageorgiou N; Tsioufis C; Kallikazaros I; Stefanadis C
    Cardiol Rev; 2009; 17(5):216-21. PubMed ID: 19690472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal and vascular hypertension-induced inflammation: role of angiotensin II.
    Ruiz-Ortega M; Esteban V; Rupérez M; Sánchez-López E; Rodríguez-Vita J; Carvajal G; Egido J
    Curr Opin Nephrol Hypertens; 2006 Mar; 15(2):159-66. PubMed ID: 16481883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiotensin IV activates the nuclear transcription factor-kappaB and related proinflammatory genes in vascular smooth muscle cells.
    Esteban V; Ruperez M; Sánchez-López E; Rodríguez-Vita J; Lorenzo O; Demaegdt H; Vanderheyden P; Egido J; Ruiz-Ortega M
    Circ Res; 2005 May; 96(9):965-73. PubMed ID: 15831814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intracellular mechanisms involved in vascular remodelling of resistance arteries in hypertension: role of angiotensin II.
    Touyz RM
    Exp Physiol; 2005 Jul; 90(4):449-55. PubMed ID: 15890798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin II and inflammation: the effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockade.
    Dandona P; Dhindsa S; Ghanim H; Chaudhuri A
    J Hum Hypertens; 2007 Jan; 21(1):20-7. PubMed ID: 17096009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Newly developed angiotensin II-infused experimental models in vascular biology.
    Qin Z
    Regul Pept; 2008 Oct; 150(1-3):1-6. PubMed ID: 18562020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiotensin II is associated with activation of NF-kappaB-mediated genes and downregulation of PPARs.
    Tham DM; Martin-McNulty B; Wang YX; Wilson DW; Vergona R; Sullivan ME; Dole W; Rutledge JC
    Physiol Genomics; 2002 Oct; 11(1):21-30. PubMed ID: 12361987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin II as a pro-inflammatory mediator.
    Phillips MI; Kagiyama S
    Curr Opin Investig Drugs; 2002 Apr; 3(4):569-77. PubMed ID: 12090726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How to explain the differences between renin angiotensin system modulators.
    Levy BI
    Am J Hypertens; 2005 Sep; 18(9 Pt 2):134S-141S. PubMed ID: 16125050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CXCR2 blockade impairs angiotensin II-induced CC chemokine synthesis and mononuclear leukocyte infiltration.
    Abu Nabah YN; Losada M; Estellés R; Mateo T; Company C; Piqueras L; Lopez-Gines C; Sarau H; Cortijo J; Morcillo EJ; Jose PJ; Sanz MJ
    Arterioscler Thromb Vasc Biol; 2007 Nov; 27(11):2370-6. PubMed ID: 17717298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inflammation and angiotensin II.
    Suzuki Y; Ruiz-Ortega M; Lorenzo O; Ruperez M; Esteban V; Egido J
    Int J Biochem Cell Biol; 2003 Jun; 35(6):881-900. PubMed ID: 12676174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The regulation of the inflammatory response through nuclear factor-kappab pathway by angiotensin IV extends the role of the renin angiotensin system in cardiovascular diseases.
    Ruiz-Ortega M; Esteban V; Egido J
    Trends Cardiovasc Med; 2007 Jan; 17(1):19-25. PubMed ID: 17210474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significance of vascular endothelial cell growth factor up-regulation mediated via a chymase-angiotensin-dependent pathway during angiogenesis in hamster sponge granulomas.
    Katada J; Muramatsu M; Hayashi I; Tsutsumi M; Konishi Y; Majima M
    J Pharmacol Exp Ther; 2002 Sep; 302(3):949-56. PubMed ID: 12183651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PPAR alpha activator fenofibrate inhibits myocardial inflammation and fibrosis in angiotensin II-infused rats.
    Diep QN; Benkirane K; Amiri F; Cohn JS; Endemann D; Schiffrin EL
    J Mol Cell Cardiol; 2004 Feb; 36(2):295-304. PubMed ID: 14871557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiotensin II enhances interleukin-18 mediated inflammatory gene expression in vascular smooth muscle cells: a novel cross-talk in the pathogenesis of atherosclerosis.
    Sahar S; Dwarakanath RS; Reddy MA; Lanting L; Todorov I; Natarajan R
    Circ Res; 2005 May; 96(10):1064-71. PubMed ID: 15860756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of bone marrow renin-angiotensin system in the pathogenesis of atherosclerosis.
    Fukuda D; Sata M
    Pharmacol Ther; 2008 May; 118(2):268-76. PubMed ID: 18439685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.